Story at a glance A newly approved treatment for clinical depression is being hailed as a potential game changer for the millions of Americans who suffer from the condition. Auvelity, from Axsome Therapeutics, marks the first drug with a different mechanism of action approved for treating depression in 60 years. In clinical trials, participants reported progress beginning at week one, and sustained benefits throughout the study window. A newly approved drug from Axsome Therapeutics, Auvelity, can improve symptoms of major depressive disorder (MDD) — also known as clinical depression — after one week of administration, making it the first and only oral rapid-ac
Hence then, the article about fda approves first fast acting oral drug for clinical depression was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA approves first fast-acting oral drug for clinical depression )